131408-21-4

Basic information

• Product Name: 4-Methoxy-3-[(1S,2S,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-benzaldehyde
• CAS NO: 131408-21-4
• Molecular Weight: 294.35
• Mol File: 131408-21-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-Methoxy-3-[(1S,2S,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methoxy-3-[(1S,2S,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-benzaldehyde(131408-21-4)
• EPA Substance Registry System: 4-Methoxy-3-[(1S,2S,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-benzaldehyde(131408-21-4)

Safety Data

• Hazardous Substances Data: 131408-21-4(Hazardous Substances Data)

Upstream product

• 621-59-0 isovanillin 
• 69618-83-3 3-exo-benzobicyclo<2.2.1>hept-2-yl formate 
• 115898-51-6 2-[(1S,2S,4S)-(1,2,3,4-Tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-phenol 
• 7374-90-5 3,4-Dihydro-1H-1,4-methano-naphthalen-2-one 
• 115919-90-9 (1S,2S,4S)-2-(5-Bromo-2-methoxy-phenoxy)-1,2,3,4-tetrahydro-1,4-methano-naphthalene 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 115919-88-5 1-methyl-5-<3-(endo-benzobicyclo<2.2.1>hept-2-yloxy)-4-methoxyphenyl>-2-imidazolidinone 
• 115897-67-1 1-{4-Methoxy-3-[(1S,2S,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-phenyl}-N¹-methyl-ethane-1,2-diamine 
• 115919-88-5 1-methyl-5-<3-(exo-benzobicyclo<2.2.1>hept-2-yloxy)-4-methoxyphenyl>-2-imidazolidinone 
• 115897-67-1 1-{4-Methoxy-3-[(1S,2R,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-phenyl}-N¹-methyl-ethane-1,2-diamine 
• 115897-65-9 {4-Methoxy-3-[(1S,2S,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-phenyl}-methylamino-acetonitrile 
• 115897-65-9 {4-Methoxy-3-[(1S,2R,4S)-(1,2,3,4-tetrahydro-1,4-methano-naphthalen-2-yl)oxy]-phenyl}-methylamino-acetonitrile 

Relevant articles and documents

Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones

The synthesis and biological properties of a novel series of selective calcium-independent phosphodiesterase inhibitors are described. These compounds also inhibit the specific binding of [3H]rolipram to rat brain membranes and exhibit efficacy